Anifrolumab (Saphnelo) listed in MB

March 10, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Manitoba effective April 1, 2024.

For more information, please visit https://www.gov.mb.ca/health/mdbif/docs/bulletins/bulletin131.pdf

Lupus Blog Articles:

Mental Health and Lupus: A Global Perspective

Read

Biogen Lupus Research | New Treatments in Development

Read

Living with Lupus: Yaneisy-Nynoska Tremblay’s Story | Lupus Canada

Read